当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 资产负债表

华兰生物

(002007)

  

流通市值:248.87亿  总市值:289.13亿
流通股本:15.74亿   总股本:18.29亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金843,155,746.522,026,889,197.51,170,608,928.52993,767,308.91
应收票据及应收账款2,368,410,452.421,750,250,436.692,103,541,671.362,295,645,462.97
应收账款2,368,410,452.421,750,250,436.692,103,541,671.362,295,645,462.97
应收款项融资145,781,458.71211,103,745.79143,686,540.8293,909,521.8
预付款项68,099,249.1871,656,956.8658,847,662.8333,532,487.63
其他应收款合计16,568,395.2516,582,814.118,857,960.396,603,222.23
存货1,905,908,043.121,921,748,320.61,923,370,621.371,673,627,088.65
一年内到期的非流动资产2,049,849,472.231,333,004,0001,136,805,555.561,213,457,527.79
其他流动资产90,094,251.3760,064,447.62151,807,870.16701,173,440.02
流动资产平衡项目0000
流动资产合计9,266,229,186.629,017,925,039.329,856,286,286.629,326,541,857.42
非流动资产:
长期股权投资6,034,995.112,990,540.7421,518,562.3726,440,405.16
固定资产2,039,752,564.372,080,861,919.152,043,970,541.272,055,070,356.28
在建工程792,268,823.88705,116,003.24724,917,405.97661,513,007.72
生产性生物资产856,329.92-367,153.15965,100.05
使用权资产9,262,562.339,405,857.579,387,452.819,516,048.05
无形资产315,925,342.79318,959,190.08321,833,264.47319,715,855.87
开发支出27,635,945.3727,442,684.4826,915,859.5326,269,230.64
商誉--1,098,329.81,098,329.8
长期待摊费用29,998,078.9732,697,776.8334,595,973.9133,331,687.55
递延所得税资产207,864,992.45242,465,836.39228,280,492.05241,724,551.62
其他非流动资产3,405,777,581.383,189,671,664.842,999,616,511.093,403,596,865.03
非流动资产平衡项目0000
非流动资产合计6,835,377,216.566,619,611,473.326,412,501,546.426,779,241,437.77
资产平衡项目0000
资产总计16,101,606,403.1815,637,536,512.6416,268,787,833.0416,105,783,295.19
流动负债:
短期借款600,000,000900,000,000800,000,000700,350,000
应付票据及应付账款204,658,855.82210,358,797.65244,123,430.79197,262,756.35
其中:应付票据6,907,33012,014,34019,863,430-
应付账款197,751,525.82198,344,457.65224,260,000.79197,262,756.35
合同负债9,792,652.4919,198,473.9910,137,064.388,573,054.1
应付职工薪酬514,696.99136,391.18492,929.4727,887.19
应交税费72,187,599.0735,666,046.9624,530,744.2887,748,157.27
其他应付款合计1,252,431,049.071,017,627,468.581,081,356,685.191,286,876,534.1
应付股利93,323,867.5893,323,867.58--
一年内到期的非流动负债150,761,507.75150,761,507.75300,000,000300,355,532.62
其他流动负债293,699.54575,874.13304,000.39257,111.58
流动负债平衡项目0000
流动负债合计2,290,640,060.732,334,324,560.242,460,944,854.52,581,451,033.21
非流动负债:
租赁负债8,671,814.238,568,385.849,226,465.219,148,258.08
递延收益46,457,509.1348,085,544.2649,632,479.451,178,488.6
递延所得税负债44,740,117.7440,818,062.0841,359,138.8742,822,788.15
非流动负债平衡项目0000
非流动负债合计99,869,441.197,471,992.18100,218,083.48103,149,534.83
负债平衡项目0000
负债合计2,390,509,501.832,431,796,552.422,561,162,937.982,684,600,568.04
所有者权益(或股东权益):
实收资本(或股本)1,828,780,9261,828,780,9261,828,780,9261,828,780,926
资本公积1,446,836,942.141,483,172,018.211,495,874,900.771,485,602,043.17
减:库存股46,746,37846,746,37848,070,63848,070,638
盈余公积806,811,676.78806,811,676.78806,811,676.78806,811,676.78
未分配利润7,661,329,272.727,177,868,536.267,548,080,657.077,286,306,719.47
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计11,697,012,439.6411,249,886,779.2511,631,477,522.6211,359,430,727.42
少数股东权益2,014,084,461.711,955,853,180.972,076,147,372.442,061,751,999.73
股东权益平衡项目0000
股东权益合计13,711,096,901.3513,205,739,960.2213,707,624,895.0613,421,182,727.15
负债和股东权益合计16,101,606,403.1815,637,536,512.6416,268,787,833.0416,105,783,295.19
公告日期2024-10-302024-08-302024-04-262024-03-30
审计意见(境内)标准无保留意见
TOP↑